(Q35993038)

English

Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters

scientific article published on May 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cancer research

1 reference

10.1038/BJC.1992.158

https://api.crossref.org/works/10.1038/BJC.1992.158

4 December 2023

1 reference

10.1038/BJC.1992.158

https://api.crossref.org/works/10.1038/BJC.1992.158

4 December 2023

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

P. J. Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

N. Dobbs

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

C. Kalayci

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

M. C. Aldous

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

P. Harper

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

E. M. Metivier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

R. Williams

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

language of work or name

0 references

publication date

1 May 1992

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

full work available at URL

https://europepmc.org/articles/PMC1977380

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

https://europepmc.org/articles/PMC1977380?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

12 September 2022

https://www.nature.com/articles/bjc1992158.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316777

4 December 2023

http://www.nature.com/articles/bjc1992158.pdf

Portable Document Format

1 reference

10.1038/BJC.1992.158

https://api.crossref.org/works/10.1038/BJC.1992.158

4 December 2023

http://www.nature.com/articles/bjc1992158

1 reference

10.1038/BJC.1992.158

https://api.crossref.org/works/10.1038/BJC.1992.158

4 December 2023

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

65

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

751-755

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1992.158

0 references

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977380

2 October 2017

Induction of remission in hepatocellular carcinoma with doxorubicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977380

2 October 2017

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977380

2 October 2017

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977380

11 July 2018

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977380

11 July 2018

A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977380

11 July 2018

Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How much does liver disease affect the pharmacokinetics of adriamycin?

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic extraction of adriamycin in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

STRIPE: an interactive computer program for the analysis of drug pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/1316777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1992.158

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35993038&oldid=2143460136"